TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Apr 06, 2026
2 min read
20

Sharps Technology Inc. reported a monumental increase in total assets to $269.1 million for the fiscal year ending December 31, 2025, a significant leap from $7.3 million in the previous year. This growth was primarily fueled by the company's strategic accumulation of over 2 million Solana SOL tokens as part of its new digital asset treasury initiative.
The company's financial performance reflects a successful pivot away from legacy operations. For fiscal year 2025, total revenue reached approximately $7.0 million, with net staking revenue contributing a dominant $6.8 million. Sharps Technology actively stakes about 95% of its SOL holdings, targeting a 7% gross annualized yield, while revenue from medical device distribution was only $204,120.
This strategic redirection has profoundly transformed the company's balance sheet. Stockholders' equity surged to $264.4 million from just $2.0 million in 2024, and total liabilities decreased to $4.7 million. The company raised over $430 million in capital during 2025 and established key partnerships with industry leaders like Coinbase, Crypto.com, and BitGo to support its new focus.
Sharps Technology has successfully transitioned from a medical device company to a digital asset-focused entity, fundamentally reshaping its financial structure around its Solana treasury. This strategic move has significantly improved its financial health and market position. The company's future performance will be closely linked to the value of SOL and the broader digital asset market.
Q: What was the main reason for Sharps Technology's asset growth?
A: The primary reason was the strategic acquisition and holding of over 2 million SOL tokens in its corporate treasury.
Q: How did the company's revenue sources change?
A: The company shifted its main revenue source from medical device sales to net staking revenue from its SOL holdings, which accounted for over 97% of total revenue in 2025.
Q: What key financial improvements did Sharps Technology report?
A: The company reported a surge in total assets to $269.1 million, an increase in stockholders' equity to $264.4 million, and a decrease in total liabilities to $4.7 million.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles